Improved results in cadaveric transplantation using cyclosporine for immunosuppression have led to the suggestion that one advantage (improved graft function) of LRD has been lost. This would be true only if cyclosporine did not improve the results in LRD transplants, too. A comparison of the results of LRD (HLA-identical and HLA-nonidentical) and CAD graft and patient survival prior to and after the use of cyclosporine is presented.
|Original language||English (US)|
|Number of pages||2|
|Issue number||1 SUPPL. 1|
|State||Published - 1988|